| BMs | brain metastases |
| EOR | extent of resection |
| SF | sodium fluorescein |
| KPS | Karnofsky Performance Status |
| NSCLC | non-small cell lung cancer |
| SCLC | small cell lung cancer |
| BBB | blood-brain barrier |
| OS | overall survival |
| QoL | quality of life |
| FGS | fluorescence-guided surgery |
| HGGs | high-grade gliomas |
| 5-ALA | 5-aminolevulinic acid |
| FDA | Food and Drug Administration |
| CUCH | Chongqing University Cancer Hospital |
| MRI | magnetic resonance imaging |
| GTR | gross total resection |
| RANO-BM | Response Assessment in Neuro-Oncology Brain Metastases |
| N | no residual |
| U | unmeasurable residual |
| M | measurable residual |
| HR | hazard ratios |
| ICG | indocyanine green |